Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)

Overview of attention for article published in The Lancet, September 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news: 34 news outlets
blogs: 2 blogs
policy: 2 policy sources
twitter: 610 X users
patent: 5 patents

facebook: 1 Facebook page
reddit: 4 Redditors
video: 1 YouTube creator
podcasts: 2 podcasts

Readers on

mendeley: 262 Mendeley

So far, Altmetric has seen 4 Reddit threads by 4 users.

These are some of what I found that convinced me to wait a...

User taykmdown, in the Novavax_vaccine_talk subreddit, 25 Jul 2022

These are some of what I found that convinced me to wait a bit longer. https://www.aamc.org/news-insights/canada-took-risk-dela…

> And fitting you use chicken pox as a comparison given...

User Similar-Struggle6871, in the CoronavirusDownunder subreddit, 14 Sep 2021

> And fitting you use chicken pox as a comparison given that it's little more than an annoyance in…

Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)

User NavSpaghetti, in the postandreact subreddit, 04 Sep 2021

Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)

User enterpriseF-love, in the COVID-19 subreddit, 02 Sep 2021

This page shows the most recent Reddit threads that mention this research output. Click here to find out how to access more activity.